OMC

OUP Management Company Portfolio holdings

AUM $44.5M
This Quarter Return
-22.47%
1 Year Return
+54.04%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
Cap. Flow
-$19.1M
Cap. Flow %
-14.56%
Top 10 Hldgs %
93.12%
Holding
16
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

1
CNTA
Centessa Pharmaceuticals
CNTA
$5.34M

Top Sells

1
IONQ icon
IonQ
IONQ
$23.3M
2
SERA icon
Sera Prognostics
SERA
$1.15M

Sector Composition

1 Healthcare 73.79%
2 Technology 22.53%
3 Industrials 3.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IONQ icon
1
IonQ
IONQ
$12.8B
$29.6M 22.53%
2,319,519
-1,827,562
-44% -$23.3M
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.32B
$26.4M 20.06%
2,937,615
+595,724
+25% +$5.34M
PMVP icon
3
PMV Pharmaceuticals
PMVP
$79M
$20.6M 15.68%
989,232
– –
JBIO
4
Jade Biosciences, Inc. Common Stock
JBIO
$249M
$11.1M 8.43%
603,762
– –
DICE
5
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$10.3M 7.82%
536,693
– –
CYT
6
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$9.33M 7.1%
2,474,572
– –
EVLV icon
7
Evolv Technologies
EVLV
$1.4B
$4.83M 3.67%
1,820,866
– –
EFTR
8
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$4.11M 3.13%
1,025,697
– –
DTIL icon
9
Precision BioSciences
DTIL
$58.9M
$3.46M 2.64%
1,123,913
– –
LABP
10
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$2.7M 2.05%
1,827,478
– –
VOR icon
11
Vor Biopharma
VOR
$258M
$2.26M 1.72%
374,714
– –
SPRO icon
12
Spero Therapeutics
SPRO
$115M
$2.17M 1.65%
249,070
– –
LENZ
13
LENZ Therapeutics
LENZ
$1.12B
$2.07M 1.58%
406,308
– –
SERA icon
14
Sera Prognostics
SERA
$127M
$1.28M 0.97%
337,505
-303,856
-47% -$1.15M
RNAC icon
15
Cartesian Therapeutics
RNAC
$256M
$1.06M 0.81%
862,543
– –
QTTB icon
16
Q32 Bio
QTTB
$20.9M
$195K 0.15%
64,000
– –